Synonyms | KS-00000ISS SR-05000001928 AB00639940_11 LS-161334 V-120
AK-58790 N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine Valsartan (JAN/USAN/INN) BC204156 N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material BSPBio_003501 (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid walsartan (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid DB00177 (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine EZR-104 NSC-758927 3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid HMS2232F05 S-6418 4997-EP2298776A1 J10013 SMR000466318 Spectrum2_001120 80M03YXJ7I L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- SW197658-2 AC-4543 Miten Valpression AM90287 N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard BG0645 Valtan CCG-221275 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid CS-1967 (S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid Diovan, Valsartan N-Valeryl-N-[2'-(5-tetrazolyl)biphenyl-4-ylmethyl]-L-valine (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine GTPL3937 Prexxartan 4997-EP2272841A1 HSDB 7519 Sanol brand of valsartan 4997-EP2301931A1 KBio2_004855 KBioGR_001078 Spectrum5_001582 AB00639940-08 L-Valsartan TR-031794 ACT02671 MolPort-002-507-854 Aventis brand of valsartan N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine Valsartan, >=98% (HPLC) BRD-K45158365-001-02-3 Valzaar (TN) CGP-48933 (2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid D06UDG (S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Esteve brand of valsartan Nisis 2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid HMS2051L12 PubChem9865 4997-EP2295422A2 I997 SCHEMBL2542 4997-EP2308562A2 SPBio_001260 KS-1194 SR-05000001928-1 AB07510 MCULE-6728882368 VA11929 AKOS015914315 N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine Valsartan (JP17/USAN/INN) BCP05184 N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine Valsartan, United States Pharmacopeia (USP) Reference Standard C24H29N5O3 (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid ZINC3875259 CHEMBL1069 (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid Diovan (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine FT-0631156 NSC758927 HMS3651E04 s1894 4997-EP2298779A1 Kalpress KBio2_007423 Spectrum3_001831 AB0013966 L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI) Tareg AC1L1U1M MLS000759423 Vals AN-7255 N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE Valsartan [USAN:INN] BIDD:GT0345 Valtan (TN) CEPA brand of valsartan (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid D00400 (s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid DS-1248 N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine 137862-53-4 GTPL593 Prexxartan (oral solution) 4997-EP2277879A1 HY-18204 SBI-0206738.P001 4997-EP2301936A1 KBioSS_002289 Spectrum_001796 AB00639940_09 Lacer brand of valsartan UNII-80M03YXJ7I ACWBQPMHZXGDFX-QFIPXVFZSA-N MolPort-003-666-608 valsartan (Diovan) AX8018200 N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine Valsartan, European Pharmacopoeia (EP) Reference Standard BRD-K45158365-001-05-6 Varexan CHEBI:9927 (5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid (S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Exforge Novartis brand of valsartan 3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid HMS2093K22 RTR-031794 4997-EP2298772A1 J-007068 Schwarz brand of valsartan 4997-EP2308839A1 SPECTRUM1505209 62V534 L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)- ST2408288 AB2000354 MFCD00865840 VAL-489 AKOS015994698 N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard BDBM50049186 N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine Valsartan,(S) CCG-101028 (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid [3H]valsartan CPD000466318 (s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid Diovan (TN) (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine GP8514 Pharmakon1600-01505209 4997-EP2270011A1 HMS3715P12 SAM001246581 4997-EP2301923A1 KBio2_002287 KBio3_003006 Spectrum4_000749 AB00639940-06 L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- TL8000869 AC1Q5QIK MLS001424088 Valsarran ANW-49040 N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine Valsartan [USAN:USP:INN:BAN] BR-58790 Valzaar CGP 48933 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid. D04HSR (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid EC 604-045-2 NC00278 137863-60-6 HMS1922L21 Provas 4997-EP2295406A1 I14-41498 SC-00971 4997-EP2305219A1 [ Show all ] |
---|
Inchi ID | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 |
---|